MENU

News

Latest News Articles

News

06.30.20

Chronic Stress of Discrimination Increases Hypertension Risk in African Americans
  • KEYWORDS:
  • high blood pressure
  • hypertension
  • Intracranial hypertension
  • Stroke

News

06.30.20

FDA Grants Orphan Drug Designation for Primary Mitochondrial Myopathies Treatment
  • KEYWORDS:
  • Neuromuscular disease
  • peroxisome proliferator activated receptor
  • primary mitochondrial myopathies
  • REN001

News

06.26.20

FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
  • KEYWORDS:
  • Dravet syndrome
  • FDA Approvals
  • Fenfluramine
  • Seizures

News

06.24.20

Higher Rates of Alzheimer Disease Not Related to Longer Life in Women
  • KEYWORDS:
  • Alzheimer Disease
  • Early onset Alzheimer disease

News

06.24.20

Phase 2 Clinical Trial for Stem-Cell Treatment of Alzheimer Disease Planned
  • KEYWORDS:
  • Alzheimer Disease
  • Autologous Treg cells
  • Early onset Alzheimer disease
  • MSC-NTF
  • NurOwn

News

06.23.20

FDA Grants Premarket Approval for Neurostimulation System for Chronic Back Pain
  • KEYWORDS:
  • 2020 Drug and Device Approvals
  • implantable neurostimulation system
  • Pain

News

06.22.20

Enrollment Begins for Phase 1b Clinical Trial of T-cell Immunotherapy for Progressive Multiple Sclerosis 
  • KEYWORDS:
  • allogeneic EBV T-cell immunotherapy
  • ATA188
  • Multiple sclerosis

News

06.19.20

Metabolomics May Be a Potential Biomarker for Autism
  • KEYWORDS:
  • Autism
  • Child neurology

News

06.18.20

New Indication for Pimavanserin—Dementia Related Psychosis—Submitted to the FDA 
  • KEYWORDS:
  • Alzheimer Disease
  • Dementia
  • Early onset Alzheimer disease
  • Pimavanserin

News

06.17.20

Phase 2 Trial of Tauroursodeoxycholic Acid for Alzheimer Disease Completes Enrollment
  • KEYWORDS:
  • Alzheimer Disease
  • Early onset Alzheimer disease
  • Taurursodiol-phenylbutyrate

News

06.17.20

Galcanezumab Reduces Episodic and Chronic Migraine Pain Burden
  • KEYWORDS:
  • Galcanezumab
  • Headache
  • Migraine

News

06.16.20

Risdiplam Improves Motor Symptoms in Spinal Muscular Atrophy
  • KEYWORDS:
  • Movement disorders
  • Risdiplam
  • Spinal muscular atrophy

News

06.15.20

Eptinezumab Reduced Use of Acute Migraine Treatments and Resolved Medication Overuse Headache
  • KEYWORDS:
  • Eptinezumab
  • Eptinezumab
  • Headache
  • Medication-overuse headache
  • Migraine

News

06.12.20

FDA Approves Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder
  • KEYWORDS:
  • FDA Approvals
  • Inebilizumab
  • neuromyelitis optica spectrum disorder
  • NMOSD
Show More
This Month's Issue
Teleneurology for Neuromuscular Conditions

Vanessa Baute Penry, MD; Rachana Gandhi Mehta, MD; and Fatemeh Sadeghifar, BS

Teleneurology for Primary Headache Disorders

Jennifer Robblee, MD, MSc; Amaal J. Starling, MD; Rashmi B. Halker Singh, MD, FAHS, FAAN; and Nina Riggins, MD, PhD